Audited financial results for financial year ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 18.6 pts more than Nifty Microcap 250 and 18.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Resonance Specialties reported a strong FY25 with revenue from operations rising about 41% to Rs. 7,780.66 lakhs (vs Rs. 5,530.09 lakhs in FY24), driven by both domestic growth (India revenue up ~80%) and steady export revenue. Profit after tax jumped about 121% to Rs. 656.62 lakhs (vs Rs. 296.84 lakhs), with EPS rising to Rs. 5.65 from Rs. 2.56. Q4FY25 also showed a sharp jump — revenue up ~48% YoY and PAT up over 4.5x. The Board declared a dividend of Re. 1 per share (10%) with record date July 29, 2025. Statutory auditor Kailash Chand Jain & Co. issued an unmodified (clean) opinion. However, operating cash flow turned negative at Rs. (197.82) lakhs vs positive Rs. 416.37 lakhs last year, mainly due to a large build-up in trade receivables and inventory.
Strong top-line and profit growth, a maiden dividend, and a clean audit report are positive for shareholders. The sharp swing to negative operating cash flow despite higher profits is a watch point — it suggests the company is funding growth through working capital stretch, which may pressure liquidity if it continues.